Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Narrow Band Imaging in Diagnosis of Colorectal Polyps

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04831814
Recruitment Status : Completed
First Posted : April 5, 2021
Last Update Posted : May 12, 2021
Sponsor:
Information provided by (Responsible Party):
Nisa Netinatsunton, Prince of Songkla University

Brief Summary:
Optical diagnosis of colorectal polyps is a promising tool to avoid risks of unnecessary polypectomies and to save costs of tissue pathology. NICE (NBI International Colorectal Endoscopic) and WASP (Workgroup on Serrated Polyps and Polyposis) classification were developed for diagnosis of adenomatous and sessile serrated polyps, respectively.

Condition or disease Intervention/treatment Phase
Colorectal Polyp Colorectal Neoplasms Diagnostic Test: Near Focus NBI Diagnostic Test: Standard Focus NBI Not Applicable

Detailed Description:
Near-focus (NF) narrow-band imaging (NBI) is an image-magnifying technology which enables optical magnification of up to 65x in near focus (NF) compared with 52x in normal standard focus (SF) with the simple push of a button of the endoscope to be interchangeable between NF and SF. There were few studies comparing diagnostic accuracy between NF and SF in the diagnosis of colorectal polyps. So, our aim of the current study is to compare accuracy of NF NBI compared with SF NBI in the optical diagnosis of neoplastic and non-neoplastic polyp and the accuracy of NF NBI versus SF NBI in distinguishing serrated adenoma from hyperplastic polyp in sessile lesions using histologic evaluation as the gold standard.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 118 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Near-focus Versus Normal-focus Narrow Band Imaging Colonoscopy in Diagnosis of Colorectal Polyps Based on Combined NICE and WASP Classification: a Randomized Controlled Trial
Actual Study Start Date : April 4, 2019
Actual Primary Completion Date : July 2, 2020
Actual Study Completion Date : January 14, 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Colonoscopy

Arm Intervention/treatment
Experimental: Near Focus NBI
Use of the Near Focus NBI to make optical diagnosis
Diagnostic Test: Near Focus NBI
Colonoscopy with near focus narrowing band imaging technology . Optical specifications include a 2 mm near field focal depth. Optical diagnosis of polyps were according to NICE and WASP, respectively.

Active Comparator: Standard Focus NBI
Use of the Standard Focus NBI to make optical diagnosis
Diagnostic Test: Standard Focus NBI
Colonoscopy with narrow band imaging technology.Optical diagnosis of polyps were according to NICE and WASP, respectively.




Primary Outcome Measures :
  1. Rate of accurate polyp histology predictions by the Endoscopists in the two groups. [ Time Frame: At the time of procedure ]
    Measure of the percentage of accurate predictions by the endoscopists in the differentiation of neoplastic from non neoplastic colorectal lesions, using the high definition NBI colonoscopy with and without near focus features

  2. Rate of accurate diagnosis of sessile serrated polyps/adenoma by the Endoscopists in the two groups. [ Time Frame: At the time of procedure ]
    Measure of the percentage od accurate predictions by the endoscopists in the differentiation of sessile serrated polyps/adenoma from hyperplastic polyps, using the high definition NBI colonoscopy with and without near focus features.


Secondary Outcome Measures :
  1. The polyp detection rate [ Time Frame: At the time of procedure ]
    The prevalence of patients with at least one polyp was detected

  2. The adenoma detection rate [ Time Frame: At the time of procedure ]
    The prevalence of patients with at least one adenoma was detected

  3. Diagnostic Characteristics [ Time Frame: At the time of procedure ]
    Compare the diagnostic characteristic (sensitivity, specificity, positive predictive value and negative predictive value) using the high definition narrow band imaging colonoscopy with and without near focus features.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients who were scheduled for colonoscopy at NKC institute

Exclusion Criteria:

  • Inflammatory bowel disease
  • Polyposis syndrome
  • Colorectal cancer
  • Active gastrointestinal bleeding
  • Pregnant woman
  • Inadequate bowel preparation
  • Contraindication for polyps removal

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04831814


Locations
Layout table for location information
Thailand
Prince Songkla University
Hat Yai, Songkhla, Thailand, 90110
Sponsors and Collaborators
Prince of Songkla University
Investigators
Layout table for investigator information
Principal Investigator: NISA NETINATSUNTON, MD. NKC Institute of Gastroenterology and Hepatology, Prince of Songkla University
Layout table for additonal information
Responsible Party: Nisa Netinatsunton, Principal Investigation, Prince of Songkla University
ClinicalTrials.gov Identifier: NCT04831814    
Other Study ID Numbers: 61355143
First Posted: April 5, 2021    Key Record Dates
Last Update Posted: May 12, 2021
Last Verified: March 2021

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Colorectal Neoplasms
Polyps
Pathological Conditions, Anatomical
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases